Phibro Animal Health (PAHC) Set to Announce Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC) will post its quarterly earnings results after the market closes on Wednesday, November 6th. Analysts expect Phibro Animal Health to post earnings of $0.23 per share for the quarter. Phibro Animal Health has set its FY 2025 guidance at 1.220-1.370 EPS.Individual that wish to register for the company’s earnings conference call can do so using this link.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.07. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. The company had revenue of $273.16 million for the quarter, compared to analyst estimates of $262.44 million. On average, analysts expect Phibro Animal Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Phibro Animal Health Price Performance

Shares of NASDAQ:PAHC opened at $23.50 on Wednesday. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79. The firm has a market capitalization of $951.75 million, a PE ratio of 391.73, a PEG ratio of 0.58 and a beta of 0.52. Phibro Animal Health has a 1-year low of $9.40 and a 1-year high of $25.11. The business’s 50 day moving average is $21.83 and its 200-day moving average is $18.79.

Insider Buying and Selling at Phibro Animal Health

In other Phibro Animal Health news, Director E Thomas Corcoran acquired 5,000 shares of the business’s stock in a transaction on Wednesday, September 4th. The stock was purchased at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the transaction, the director now owns 25,000 shares in the company, valued at $500,500. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 50.07% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on PAHC shares. Bank of America raised their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. JPMorgan Chase & Co. started coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price for the company. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, Phibro Animal Health currently has a consensus rating of “Hold” and an average target price of $15.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.